Sustained atrial fibrillation, but not paroxysmal atrial fibrillation, was associated with a higher risk of cardiovascular death or heart failure hospitalization compared to no AF (HR 1.09; 95% CI 1.01-1.17; P=0.03).
Cohort (n=12,895)
Yes
Does atrial fibrillation type (paroxysmal vs sustained) affect the risk of cardiovascular death or heart failure hospitalization in hospitalized patients with acute heart failure?
Sustained atrial fibrillation, but not paroxysmal atrial fibrillation, is associated with an increased risk of cardiovascular death or heart failure hospitalization in patients hospitalized for acute heart failure.
Effect estimate: HR 1.09 (95% CI 1.01-1.17)
p-value: p=0.03
AIMS: Atrial fibrillation (AF) type (paroxysmal, persistent, or permanent) is important in determining therapeutic management; however, clinical outcomes by AF type are largely unknown for hospitalized patients with heart failure (HF). METHODS AND RESULTS: The Japanese Registry Of Acute Decompensated Heart Failure is a retrospective, multicenter, and nationwide registry of patients hospitalized for acute HF in Japan. Follow-up data were collected up to 5 years after hospitalization. Patients were divided based on diagnosis and AF type into 3 groups without AF, paroxysmal AF, and sustained AF (defined as a composite of persistent and permanent AF), and compared the backgrounds and outcomes between the groups. Of 12 895 hospitalized HF patients mean age: 78 ± 13 years, female: 6077 (47%), and mean left ventricular ejection fraction: 47 ± 17%, 1725 had paroxysmal AF, and 3672 had sustained AF. Compared with patients without AF, sustained AF had a higher risk of the primary composite endpoint of cardiovascular (CV) death or HF hospitalization hazard ratio (HR): 1.09, 95% confidence interval (CI): 1.01-1.17; P = 0.03, mainly driven by HF hospitalization HR: 1.16, 95% CI: 1.06-1.26; P < 0.001, whereas the corresponding risk for the primary endpoint in patients with paroxysmal AF was not elevated (HR: 1.03, 95% CI: 0.94-1.13; P = 0.53) after adjustment by multivariable Cox regression analysis. These results were consistent among the subgroups of patients with reduced or preserved ejection fraction (interaction P = 0.74). CONCLUSION: Among hospitalized patients with HF, sustained AF, but not paroxysmal AF, was significantly associated with a higher risk for CV death or HF hospitalization, indicating the importance of accounting for AF type in HF patients.
Hamatani et al. (2024) conducted a cohort in Acute heart failure (n=12,895). Sustained atrial fibrillation vs. Without atrial fibrillation was evaluated on Composite of cardiovascular death or heart failure hospitalization (HR 1.09, 95% CI 1.01-1.17, p=0.03). Sustained atrial fibrillation, but not paroxysmal atrial fibrillation, was associated with a higher risk of cardiovascular death or heart failure hospitalization compared to no AF (HR 1.09; 95% CI 1.01-1.17; P=0.03).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: